Magnetic resonance morphometry of the brain in the advanced stages of Parkinson's disease and vascular parkinsonism

Introduction. MR-morphometry is a method of image processing independent of the researcher, which allows you to get the results of measuring the volume of the brain structures and the thickness of various areas of the cortex and helps in the differential diagnosis in assessing the results of MRI. Our study used MR-morphometry to identify structural markers in the differential diagnosis of vascular parkinsonism in the examination of patients with Parkinson's symptoms. Purpose of research. Visualization of the distribution of atrophic changes in brain structures in vascular parkinsonism and in the advanced stages of Parkinson's disease, as well as the identification of characteristic parts of the brain that undergo a pathological process to increase the accuracy of differential diagnosis. Materials and methods. The results of magnetic resonance morphometry of patients using the postprocessing of native MR images using Freesurfer software are analyzed. We examined 29 patients with vascular parkinsonism and 19 patients with Parknison disease, at stage 4 according to Hyun and Yar. Summary. The application of the method of postprocessing data processing of MR-morphometry allows instrumental confirmation of the clinical diagnosis, as well as to clarify the pathogenesis of neurological syndromes observed in progressive supranuclear paralysis.

1. Vale T.C., Caramelli P., Cardoso F. Clinicoradiological comparison between vascular parkinsonism and Parkinson's disease // J. Neurol. Neurosurg Psychiatry. 2015. Vol. 86, No. 5, рр. 547-553. doi: 10.1136/jnnp-2014-307867.

2. Benitez-Rivero S., Lama M.J., Huertas-Fernandez I., Alvarez de Toledo P., Caceres-Redondo M.T., Martin-Rodriguez J.F., Carrillo F., Carballo M., Palomar F.J., Mir P. Clinical features and neuropsychological profile in vascular parkinsonism // J. Neurol. Sci. 2014. Vol. 3, No. 1-2. P. 193-197. doi: 10.1016/j.jns.2014.07.046.

3. Korczyn AD. Vascular parkinsonism — characteristics, pathogenesis and treatment // Nat. Rev. Neurol. 2015. Vol. 11, No. 6. P. 319-326. doi: 10.1038/nrneurol.2015.61.

4. Litvinenko I.V., Trufanov A.G., Yurin A.A., Tarumov D.A., Skulyabin D.I., Gavrilov G.V. Parkinson's disease and parkinsonism syndromes, Tutorial, Kazan, 2018, 54 р. (In Russ.).

5. Sandalov S.A., Buryak A.B., Yurin A.A., Litvinenko I.V., Trufanov A.G. The study of the average diffusivity of gray matter in patients with vascular parkinsonism. Herald of the Russian Academy of Military Medicine, 2018, No. S3, pp. 155-156 (In Russ.).

6. Sandalov S.A., Buryak A.B., Yurin A.A., Litvinenko I.V., Trufanov A.G. Features of changes in fractional anisotropy of gray matter in patients with vascular parkinsonism. Herald of the Russian Academy of Military Medicine, 2018, No. S3, рр. 156-157 (In Russ.).

7. Zijlmans J.C., Thijssen H.O., Vogels O.J., Kremer H.P., Poels P.J., Schoonderwaldt H.C., Merx J.L., van't Hof M.A., Thien T., Horstink M.W. MRI in patients with suspected vascular parkinsonism // Neurology. 1995. Vol. 45, No. 12. P. 2183-2188.

8. Rampello L., Alvano A., Battaglia G., Raffaele R., Vecchio I., Malaguarnera M. Different clinical and evolutional patterns in late idiopathic and vascular parkinsonism // J. Neurol. 2005. Vol. 252, No. 9. P. 1045-1049. doi: 10.1007/s00415-005-0811-2.

9. Demirkiran M., Bozdemir H., Sarica Y. Vascular parkinsonism: a distinct, heterogeneous clinical entity // Acta Neurol Scand. 2001. Vol. 104, No. 2. P. 63-67.

10. Dunet V., Deverdun J., Charroud C., Le Bars E., Molino F., Menjot de Champfleur S., Maury F., Charif M., Ayrignac X., Labauge P., Castelnovo G., Pinna F., Bonafe A., Geny C., Menjot de Champfleur N. Cognitive Impairment and Basal Ganglia Functional Connectivity in Vascular Parkinsonism // AJNR Am J Neuroradiol. 2016. Vol. 37, No. 12. P. 2310-2316. doi: 10.3174/ajnr.A4889.

11. Vizcarra J.A., Lang A.E., Sethi K.D., Espay A.J. Vascular Parkinsonism: deconstructing a syndrome // Movement disorders: official journal of the Movement Disorder Society. 2015. Vol. 30, No. 7. P. 886-894. doi: 10.1002/mds.26263.

12. Korczyn A.D. Vascular parkinsonism-characteristics, pathogenesis and treatment // Nature reviews Neurology. 2015. Vol. 11, No. 6. P. 319-326. doi: 10.1038/nrneurol.2015.61.

13. Choi S.M., Kim B.C., Nam T.S., Kim J.T., Lee S.H., Park M.S., Kim M.K., de Leon M.J., Cho K.H. Midbrain atrophy in vascular Parkinsonism // Eur. Neurol. 2011. Vol. 65, No. 5. P. 296-301. doi: 10.1159/000326907.

14. Focke N.K., Helms G., Scheewe S., Pantel P.M., Bachmann C.G., Dechent P., Ebentheuer J., Mohr A., Paulus W., Trenkwalder C. Individual voxel-based subtype prediction can differentiate progressive supranuclear palsy from idiopathic Parkinson syndrome and healthy controls // Hum Brain Mapp. 2011. Vol. 32, No. 11. P. 1905-1915. doi: 10.1002/hbm.21161.

15. Trufanov A.G., Litvinenko I.V., Yurin A.A., Trufanov G.E., Buryak A.B. Modern possibilities of magnetic resonance imaging in the diagnosis of parkinsonism syndrome. Russian Electronic Journal of Radiology, 2018, Vol. 8, No. 1, рр. 52-65 (In Russ.).

16. Fokin V.A., Trufanov A.G., Litvinenko I.V., Odinak M.M., Voronkov L.V., Efimtsev A.Yu., Yurin A.A., Trufanov G.E. Magnetic resonance imaging in the differential diagnosis of vascular parkinsonism. Translational medicine, 2016, Vol. 3, No. 5, рр. 103-112 (In Russ.).

17. Iskhakova E.V., Trufanov A.G., Yurin A.A., Lepekhina A.S., Efimtsev A.Yu., Fokin V.A. Magnetic resonance morphometry of the brain in different variants of multisystem atrophy. Diagnostic radiology and radiotherapy, 2020. Vol. 11, No. 1, рр. 33-37 (In Russ.).